PMID: 11337284May 19, 2001Paper

Efficacy of chemotherapy for prostatic tuberculosis-a clinical and histologic follow-up study

Urology
Y LeeJ Huang

Abstract

To characterize the clinical features of prostatic tuberculosis and to evaluate the short and long-term results of antituberculous chemotherapy. Eighteen patients (mean age 66.7 +/- 10.2 years) with prostatic tuberculosis were included in this study. The median pretreatment prostate-specific antigen (PSA) level was 2.7 ng/mL (range 0.3 to 31). The PSA level was greater than 4.0 ng/mL in 6 patients (33.3%). Eight patients (44.4%) received a triple-drug regimen of rifampin, ethambutol, and isoniazid for more than 6 months. The mean duration of chemotherapy was 7.6 months (range 6 to 12). Of the 8 patients, 3 underwent chemotherapy longer because of concurrent tuberculosis of other organs. Follow-up studies included digital rectal examination, total PSA determination, and transrectal prostate biopsy. Ten patients were eligible for regular follow-up. All the patients were symptom free during follow-up. The median length of follow-up was 3.4 years (range 1 to 9). The average number of follow-up transrectal prostate biopsies was 2.4 (range 2 to 3). The follow-up histologic findings showed nodular hyperplasia in 7 patients and chronic inflammatory cell infiltration in 3 patients. No acid-fast bacillus was found in any follow-up specim...Continue Reading

References

Aug 1, 1979·British Journal of Urology·J G Gow
Oct 1, 1979·Seminars in Roentgenology·A K Tonkin, D M Witten
Apr 1, 1978·Urology·A Sporer, O Auerbach
May 1, 1976·Disease-a-month : DM·R L Mayock, R R MacGregor
May 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·H LupatkinM S Simberkoff
Jan 31, 1991·The New England Journal of Medicine·P M SmallP C Hopewell
Aug 1, 1987·The American Journal of Medicine·M WeinbergerS Pitlik
Sep 1, 1987·Revista Do Instituto De Medicina Tropical De São Paulo·F J de PaulaE Sabbaga
May 1, 1987·AJR. American Journal of Roentgenology·B A ThornhillJ C Hoffman-Tretin
Dec 1, 1987·The American Review of Respiratory Disease·M D Iseman
Jun 1, 1982·Urology·J J KaufmanJ Waisman
Oct 1, 1981·British Journal of Diseases of the Chest·W Fox
Dec 1, 1994·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·M C RaviglioneA Kochi
Feb 25, 1993·The New England Journal of Medicine·M GobleC R Horsburgh
Jul 15, 1996·Annals of Internal Medicine·L E Wolf
Jul 1, 1997·Annals of Internal Medicine·T A KenyonK Castro
Sep 18, 1997·The Journal of Infectious Diseases·C M Nolan
Jun 4, 1999·Diagnostic Microbiology and Infectious Disease·G FätkenheuerR Wenzel

❮ Previous
Next ❯

Citations

Jun 14, 2005·European Journal of Radiology·Maria João MatosIsabel Ramos
May 27, 2009·Indian Journal of Urology : IJU : Journal of the Urological Society of India·Nitin GuptaS K Singh
May 13, 2008·The Lancet Infectious Diseases·Jesse T JacobSusan M Ray
Sep 11, 2012·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Jan OlssonFredrik Elgh
Oct 7, 2006·Journal of Clinical Ultrasound : JCU·Sadýk TamselGulgun Demirpolat
Jul 15, 2011·Korean journal of urology·Chul Jang KimKeita Takimoto
Aug 31, 2017·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Eduardo Kaiser Ururahy Nunes FonsecaRonaldo Hueb Baroni
Aug 2, 2014·Therapeutic Advances in Urology·Ekaterina KulchavenyaVictor Khomyakov
Jun 5, 2013·Therapeutic Advances in Urology·Ekaterina Kulchavenya
May 10, 2006·British Journal of Hospital Medicine·V RachapalliR Awasthi
Jan 15, 2017·Microbiology Spectrum·André A FigueiredoMiguel Srougi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.